Ovid Therapeutics

Ovid Therapeutics, based in Chicago, IL, is dedicated to improving the lives of individuals and families affected by neurological diseases, particularly epilepsy and cerebral cavernous malformations. The company focuses on developing next-generation targeted small molecule therapies aimed at reducing seizures and enhancing safety and tolerability through innovative mechanisms of action.

With a mission driven by science and a commitment to patient needs, Ovid Therapeutics seeks to pioneer effective new treatments that create new possibilities and more good days for those impacted by brain conditions. Their work is deeply personal, informed by the insights of the communities they serve, as they strive to make a meaningful difference in the lives of patients.

Generated from the website